NewAmsterdam Pharma Company NV (NAMS) Q1 2023 Earnings

31MayExpected
Aug 22
Oct 22
Q4 2022
Q1 2023
-1.14
-0.76
-0.38
0

Details

Expected EPS
-0.5066
Actual EPS
0
Surprise EPS
0.51
Surprise Percent
+100%

Description

NewAmsterdam Pharma Company NV (NAMS) will report earnings of for Q1 2023 on May 31, 2023.

0 Comments

Share your thoughts